PGIM Jennison Health Sciences Fund- Class R6
PHLQX
NASDAQ
Weiss Ratings | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C+ | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | PGIM Investments | |||
Manager/Tenure (Years) | Debra Netschert (10), Daniel Matviyenko (4) | |||
Website | http://www.prudentialfunds.com | |||
Fund Information | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | PGIM Jennison Health Sciences Fund- Class R6 | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Jan 27, 2016 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.93% | |||
Dividend | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.81% | |||
Asset Allocation | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 2.74% | |||
Stock | 97.26% | |||
U.S. Stock | 80.56% | |||
Non-U.S. Stock | 16.70% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -3.21% | |||
30-Day Total Return | -0.95% | |||
60-Day Total Return | 1.49% | |||
90-Day Total Return | -1.84% | |||
Year to Date Total Return | -5.52% | |||
1-Year Total Return | -10.03% | |||
2-Year Total Return | 11.29% | |||
3-Year Total Return | 20.59% | |||
5-Year Total Return | 37.95% | |||
Price | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $41.53 | |||
1-Month Low NAV | $41.22 | |||
1-Month High NAV | $42.91 | |||
52-Week Low NAV | $38.29 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $55.21 | |||
52-Week High Price (Date) | Aug 30, 2024 | |||
Beta / Standard Deviation | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.56 | |||
Standard Deviation | 13.85 | |||
Balance Sheet | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 1.31B | |||
Operating Ratios | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.77% | |||
Turnover Ratio | 79.00% | |||
Performance | PHLQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 8.73% | |||
Last Bear Market Total Return | -9.31% | |||